166 related articles for article (PubMed ID: 8396223)
1. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
2. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF
Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
[TBL] [Abstract][Full Text] [Related]
6. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
Spada A; Arosio M; Bochicchio D; Bazzoni N; Vallar L; Bassetti M; Faglia G
J Clin Endocrinol Metab; 1990 Dec; 71(6):1421-6. PubMed ID: 1977758
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
Landis CA; Harsh G; Lyons J; Davis RL; McCormick F; Bourne HR
J Clin Endocrinol Metab; 1990 Dec; 71(6):1416-20. PubMed ID: 2121775
[TBL] [Abstract][Full Text] [Related]
9. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
Faglia G; Arosio M; Spada A
Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
[TBL] [Abstract][Full Text] [Related]
10. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
11. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
[TBL] [Abstract][Full Text] [Related]
12. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
Johnson MC; Codner E; Eggers M; Mosso L; Rodriguez JA; Cassorla F
J Pediatr Endocrinol Metab; 1999; 12(3):381-7. PubMed ID: 10821217
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
Adams EF; Lei T; Buchfelder M; Bowers CY; Fahlbusch R
Mol Endocrinol; 1996 Apr; 10(4):432-8. PubMed ID: 8721987
[TBL] [Abstract][Full Text] [Related]
14. Gs protein mutations and the pathogenesis and function of pituitary tumors.
Harris PE
Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of growth-hormone-secreting human pituitary tumours: biochemical consequences and potential clinical significance.
Adams EF; Buchfelder M; Lei T; Petersen B; Fahlbusch R
Acta Neurochir Suppl; 1996; 65():7-10. PubMed ID: 8738483
[TBL] [Abstract][Full Text] [Related]
17. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein.
Kim K; Sanno N; Arai K; Takano K; Yasufuku-Takano J; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888
[TBL] [Abstract][Full Text] [Related]
19. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
20. cAMP pathway and pituitary tumorigenesis.
Lania A; Mantovani G; Spada A
Ann Endocrinol (Paris); 2012 Apr; 73(2):73-5. PubMed ID: 22525824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
